ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?

被引：6
|
作者：
Nichetti, Federico [1 ]
Lo Russo, Giuseppe [1 ]
Prelaj, Arsela [1 ]
Provenzano, Leonardo [1 ]
de Braud, Filippo [1 ,2 ]
Cabiddu, Mary [3 ]
Garassino, Marina Chiara [1 ]
Petrelli, Fausto [3 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Via Venezian 1, I-20133 Milan, Italy
[2] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
[3] ASST Bergamo Ovest, Med Oncol Unit, I-24047 Treviglio, BG, Italy
来源：
THROMBOSIS RESEARCH | 2020年 / 194卷
关键词：
Non-Small-Cell Lung Cancer; Thromboembolic events; Thrombosis; ALK; ROS-1; Tyrosine kinase inhibitors; VENOUS THROMBOEMBOLISM;
D O I：
10.1016/j.thromres.2020.06.041
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：176 / 177
页数：2
相关论文
共 50 条
  • [41] Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
    Furugaki, Koh
    Mochizuki, Marie
    Kohno, Mirei
    Shu, Sei
    Harada, Naoki
    Yoshimura, Yasushi
    BMC CANCER, 2019, 19 (1)
  • [42] Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
    Koh Furugaki
    Marie Mochizuki
    Mirei Kohno
    Sei Shu
    Naoki Harada
    Yasushi Yoshimura
    BMC Cancer, 19
  • [43] Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer
    Lim, Sun Min
    Chang, Hyun
    Cha, Yoon Jin
    Liang, Shile
    Tai, Yan Chin
    Li, Gu
    Pestova, Ekaterina
    Policht, Frank
    Perez, Thomas
    Soo, Ross A.
    Park, Won Young
    Kim, Hye Ryun
    Shim, Hyo Sup
    Cho, Byoung Chul
    LUNG CANCER, 2017, 111 : 79 - 83
  • [44] Iruplinalkib (WX-0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer
    Yang, Yingying
    Zheng, Qingmei
    Wang, Xinmei
    Zhao, Shuyong
    Huang, Wenshu
    Jia, Linchao
    Ma, Cuicui
    Liu, Shicong
    Zhang, Yongpeng
    Xin, Qianqian
    Sun, Yan
    Zheng, Shansong
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (02) : 254 - 266
  • [45] Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study
    Conde, Esther
    Hernandez, Susana
    Martinez, Rebeca
    Angulo, Barbara
    De Castro, Javier
    Collazo-Lorduy, Ana
    Jimenez, Beatriz
    Muriel, Alfonso
    Luis Mate, Jose
    Moran, Teresa
    Aranda, Ignacio
    Massuti, Bartomeu
    Rojo, Federico
    Domine, Manuel
    Sansano, Irene
    Garcia, Felip
    Felip, Enriqueta
    Mancheno, Nuria
    Juan, Oscar
    Sanz, Julian
    Luis Gonzalez-Larriba, Jose
    Atienza-Cuevas, Lidia
    Arriola-Arellano, Esperanza
    Abdulkader, Ihab
    Garcia-Gonzalez, Jorge
    Camacho, Carmen
    Rodriguez-Abreu, Delvys
    Teixido, Cristina
    Reguart, Noemi
    Gonzalez-Pineiro, Ana
    Lazaro-Quintela, Martin
    Dolores Lozano, Maria
    Gurpide, Alfonso
    Gomez-Roman, Javier
    Lopez-Brea, Marta
    Pijuan, Lara
    Salido, Marta
    Arriola, Edurne
    Company, Amparo
    Insa, Amelia
    Esteban-Rodriguez, Isabel
    Saiz, Monica
    Azkona, Eider
    Alvarez, Ramiro
    Artal, Angel
    Plaza, Maria Luz
    Aguiar, David
    Belen Enguita, Ana
    Benito, Amparo
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2120 - 2132
  • [46] Prevalence of ROS1 fusion in Chinese patients with non-small cell lung cancer
    Zhang, Qing
    Wu, Chunyan
    Ding, Wei
    Zhang, Zhihong
    Qiu, Xueshan
    Mu, Dianbin
    Zhang, Haiqing
    Xi, Yanfeng
    Zhou, Jianhua
    Ma, Liheng
    Fu, Shijun
    Gao, Min
    Wang, Bo
    Deng, Juan
    Lin, Dongmei
    Zhang, Jie
    THORACIC CANCER, 2019, 10 (01) : 47 - 53
  • [47] Real World Experience of Lorlatinib in ALK & ROS1 Rearranged Advanced NSCLC, From a Compassionate Use Program in India
    Gupta, V.
    Kapse, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1079 - S1079
  • [48] Expression and Prognostic Significance of c-Myc, ALK, ROS1, BRAF, and PD-L1 Among Patients With Non-Small Cell Lung Cancer
    Sunpaweravong, Patrapim
    Thongwatchara, Patcharaporn
    Chotipanvithayakul, Rassamee
    Sangkhathat, Surasak
    Thongsuksai, Paramee
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [49] Expression and Prognostic Significance of c-Myc, ALK, ROS1, BRAF, and PD-L1 Among Patients With Non-Small Cell Lung Cancer
    Sunpaweravong, Patrapim
    Thongwatchara, Patcharaporn
    Chotipanvithayakul, Rassamee
    Sangkhathat, Surasak
    Thongsuksai, Paramee
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [50] Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
    Lin, Jessica J.
    Langenbucher, Adam
    Gupta, Pranav
    Yoda, Satoshi
    Fetter, Isobel J.
    Rooney, Marguerite
    Do, Andrew
    Kem, Marina
    Chang, Kylie Prutisto
    Oh, Audris Y.
    Chin, Emily
    Juric, Dejan
    Corcoran, Ryan B.
    Dagogo-Jack, Ibiayi
    Gainor, Justin F.
    Stone, James R.
    Lennerz, Jochen K.
    Lawrence, Michael S.
    Hata, Aaron N.
    Mino-Kenudson, Mari
    Shaw, Alice T.
    NPJ PRECISION ONCOLOGY, 2020, 4 (01)
12345